Pfizer will not conduct a Phase III trial of its COVID-19 vaccine in the Philippines as the company is already well advanced with the study, CNN reported.
Department of Health spokesperson Maria Rosario Vergeire said talks were recently held with Pfizer about a possible product supply deal, but they made "no commitment."
Vergeire indicated that the country will finalise a confidentiality disclosure agreement with the company, as well as one with Moderna for its potential coronavirus vaccine.
Authorities from the Philippines are also set to meet with CSL the University of Queensland.
Meanwhile, the country's vaccine expert panel has sought clarifications regarding documents submitted by developers of Russia's coronavirus vaccine Sputnik V.
The documents contain the findings of Phase I and II trials of Sputnik V, with officials waiting the response from the manufacturer Gamaleya research institute.
To read more NewsPoints articles, click here.